chrisvoncsefalvay/vaers-outcomes huggingface dataset:
flu; Initial information received on 20-Feb-2022 regarding an unsolicited valid Social Media non-serious case received from a consumer/non-healthcare professional.  This case involves a 70 years unknown gender patient who had reported that I had the flu back in the very early 70's probably right about the time I had my last flu shot while receiving vaccine Influenza Vaccine.   The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient received a dose of suspect Influenza Vaccine (form, strength, route, administration site, Batch number and expiry date: unknown) produced by unknown manufacturer for immunization.  On an unknown date the patient had flu (influenza) (unknown latency) following the administration of Influenza Vaccine.  Action taken: not applicable.  Corrective treatment: not reported.  Outcome was Unknown.
Dizziness (world spinning); Foggy; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness (world spinning)) and FEELING ABNORMAL (Foggy) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DIZZINESS (Dizziness (world spinning)) and FEELING ABNORMAL (Foggy). At the time of the report, DIZZINESS (Dizziness (world spinning)) and FEELING ABNORMAL (Foggy) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.  No treatment information was provided.  For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 06-Aug-2021: Follow up received and updated the outcome of events from unknown to recovering.
Roof of mouth swelling; Mouth Swelling; Swelling of Airway; difficulty in Breathing; A spontaneous report was received from a Consumer concerning a herself, 58 years- old female patient, who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced the events, swelling of airway (respiratory tract oedema), difficulty in breathing (dyspnoea), and  roof of mouth swelling (palatal swelling), and mouth swelling.  The patient's medical history was not provided.   The concomitant medications included verapamil, triamterene, and hydrochlorothiazide  On 27 Jan 2021, prior to the onset of the events, the patient received the first of the two planned doses of mRNA-1273 (lot/batch: unknown) via unknown route for prophylaxis of COVID-19 infection.  On 27 Jan 2021 ,10 minutes after vaccination, the patient developed airway swelling and difficulty breathing. The patient was rushed to the ER, diphenhydramine and epinephrine were given which eventually resolved her symptoms. However, the next day, on 28 Jan 2021, patient noticed that the roof of her mouth was swelling up but resolved after consuming prednisolone as prescribed. Now, patient develops swelling of airways and mouth about 3 hours after any meal. Food allergy source unknown after multiple food allergy test. The events, swelling of airway, difficulty in breathing were also considered medically significant.  No Laboratory investigations were provided.   The Treatment information included Epinephrine, Benadryl and prednisolone.  Action taken with mRNA-1273 in response to the events was unknown.   The events, Swelling of Airway, and Difficulty in Breathing were considered resolved on 27 Jan 2021. The event Roof of mouth swelling was considered resolved on 28 Jan 2021.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
*Tinnitus/Pulsatile Tinnitus *Tinnitus started after 2nd dose of Moderna Covid19 Vaccine shot on 2/26/2021.  Noticed Tinnitus in March 2021. *Tinnitus during the day but more pronounced in the evening
More than two years since first vaccine; This case was reported by a consumer via interactive digital media and described the occurrence of incomplete course of vaccination in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Previously administered products included Shingles vaccine (1st dose received more than 2 years ago.).   On an unknown date, the patient did not received the 2nd dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.   Additional Information: GSK Receipt Date: 08-AUG-2022 Reporter's Comment: This case was reported by a patient via interactive digital media. The reporter stated that the more than two years ago patient received Shingles vaccine. The reporter asked patient need to restart the series. Follow-up would not possible as no contact details were available. Additional supportive information: Till the time of reporting, the patient did not receive the 2nd dose, which led to incomplete course of vaccination.
Received vaccination on or about date of conception Miscarried at 3 weeks 6 days
shortly after administering the shot the patient came up and said he was feeling light headed. had patient lay down, gave him an ice pack. after a few minutes he sat up and drank some water. checked his blood pressure twice and both times was normal. After 15 minutes he was feeling fine and his mom drove him home.
was  fully vaccinated with the Pfizer BTC vaccine; got covid-19 disease; lupus; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team for a Pfizer sponsored program.  A female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 2, single and (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), outcome "unknown", described as "was  fully vaccinated with the Pfizer BTC vaccine"; SUSPECTED COVID-19 (medically significant), outcome "unknown", described as "got covid-19 disease"; SYSTEMIC LUPUS ERYTHEMATOSUS (medically significant), outcome "unknown", described as "lupus". As the patient's brother reported: his sister was fully vaccinated with the Pfizer BTC vaccine, got covid-19 disease, had lupus and got "hit harder than anyone else."  The lot number for bnt162b2 was not provided and will be requested during follow up.
pt recvd 2nd dose of vax & devel localized soreness & generalized body tremors; No further details were provided;
Information has been received from a physician concerning a 7 yr old female who on 05Apr99 was vaccinated with a dose of varicella virus vaccine live. Concomitant vaccinations given on the same day included a dose of measles mumps rubella vaccine, a dose of hep B virus vaccine rHBsAg (yeast) and poliovirus vaccine (manf unspecified). On 06Sep05 the pt experienced about 10 slightly blistered raised bumps. Subsequently, the pt recovered on 10Sep05. Additional information has been requested.
Pt. volunteered to receive remaining dose of Yellow Fever; 0.5 ml SC given to upper rt. arm. Verbalized understanding to remain in clinic x 15 min. post-injection. Pt. left clinic and returned approx. 15-20 min. later w/ redness/rash to face and chest and c/o 5/10 chest pressure. Immediately escorted to treatment room; Dr. alerted; and EMS called code 3. 2L O2 given; IV started to left AC; 1LNS hung. VS and EKG obtained. Dr. ordered 25 mg Benadryl IV followed by 0.1mg IV high-dose epinephrine. EMS arrived; report given; sent to Hospital ED.
Patient received an incorrect Flu vaccine.  She received FluBlok ( 18 years and old) when she was only 13 years old.
This spontaneous report was received from a nurse referring to a patient of unknown age. Information about concurrent condition, concomitant medication and medical history was not provided. On 15-MAR-2019 the patient was vaccinated with RECOMBIVAX HB therapy type: Thimerosal free; lot # L044917, expiration date: 05-OCT-2018, 1 dosage form for prophylaxis (expired vaccine used). No adverse effects reported.
Initial unsolicited case received from a consumer (patient husband) on 08 Nov 2017. This case involves 78-year-old female patient who was vaccinated with one dose of FLUZONE HD (Batch number, expiry date, dose in series and site of administration were not reported) intramuscularly on 26 Oct 2017. Patient medical history includes cough, and Non-Hodgkin's Lymphoma due to which she had finished chemo 3 weeks prior. Concomitant medications were not reported. Patient was not taking any other vaccines. On 28 Oct 2017, two days after the vaccination, patient developed edema and erythema in bilateral lower and upper extremities, patient existing cough became worse, and had generalized pain. On 04 Nov 2017, few days later patient was taken to the hospital and all diagnostic tests were negative, and she was diagnosed with mild UTI (Urinary tract infection), for which the patient was given antibiotic. Other lab tests and other corrective treatment were not reported. Outcome of all the events were reported as unknown. Upon internal review the company decided to consider the case as serious, due to important medical event: Urinary tract infection. List of documents held by sender: none.; Sender's Comments: In this case patient experienced urinary tract infection post vaccination with FLUZONE HD. Though time to onset for the event is compatible with the vaccine; further information on patient's medical history, as well as etiological infectious work-up confirming the diagnosis will be required for complete assessment. Based on the information available, the role of the vaccine cannot be assessed.
Patient is fully vaccinated and boosted. COVID positive test 5/3/2022 on admission to hospital.This 69-year-old white female developed  a cough and shortness of breath over the past few days, which has gotten  progressively worse.  She is bringing some scant yellow sputum.  She had a  fever and chills. She also reports generalized weakness and has  fallen several times at home over the past few days.  Her husband reports  that she has been somewhat confused at times.  She was hypoxic on arrival to the Emergency Department,  necessitating oxygen supplementation.  Her chest x-ray shows bilateral infiltrative changes.Her hemoglobin measured  10.3 g% with hypochromic RBC indices.  The platelet count measured  479,000.  Her electrolytes were normal, but her creatinine was slightly  elevated to 1.15.  Her lactic acid was normal at 1.8.  Treatment: decadron, remdesivir, antibiotics for pneumonia coverage. Discharged home.
Swelling of shot area followed by a reddening of area around shot which progressed down arm.
on evening of 9/15/99 arm sore, whole arm & hand numb;took breathing tx as usual;still trouble breathing, sit in chair afraid to go to bed later to be w/fan in face w/some relief;pt referred to PMD;
After administering the Janssen single dose COVID vaccine at the request of the patient, she stated "it hurt less than my last COVID shot." The patient did not previously make mention she had one dose of Moderna in May. No adverse events were noted and the patient left the pharmacy.
From shoulder to arm and on upper leg; Sometimes back would hurt; Concerned; has a pull like something is "pulling" her muscles on opposite arm of the injection; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (has a pull like something is "pulling" her muscles on opposite arm of the injection), PAIN IN EXTREMITY (From shoulder to arm and on upper leg), BACK PAIN (Sometimes back would hurt) and ANXIETY (Concerned) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002A21A) for COVID-19 vaccination.     Concurrent medical conditions included Penicillin allergy.    On 23-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Feb-2021, the patient experienced MYALGIA (has a pull like something is "pulling" her muscles on opposite arm of the injection), PAIN IN EXTREMITY (From shoulder to arm and on upper leg), BACK PAIN (Sometimes back would hurt) and ANXIETY (Concerned). At the time of the report, MYALGIA (has a pull like something is "pulling" her muscles on opposite arm of the injection), PAIN IN EXTREMITY (From shoulder to arm and on upper leg), BACK PAIN (Sometimes back would hurt) and ANXIETY (Concerned) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
it was rpt by nurse concerning pt who was administered w/vax on 4/9  & a small amount of vax splashed into nurse's eye, causing a burning sensation; she flushed eye w/water;
The night of the vaccine, I started getting flu like symptoms and I didn't have any strength. Then I got a rash with redness that was itching on the left arm where I got the injection. I went to my doctor due to it spreading up to my shoulder that turned dark pink. I was prescribed an antibiotic for 10 days. The antibiotics did help clear that up. I did have other health events with your 2 vaccines. Dose 2 Moderna 01/28/2021, lot number 032L20A, I experienced severe weakness. I could not get out of the bed and I could not walk. My husband had to carry me to the bathroom. I got my 3rd dose Moderna, 10/22/2021 lot number 032F21A. A short time after that, I did get a diagnosis of Parkinson Disease.
My hands and feet fall asleep and I feel pins and needles. No treatment. What could possibly relieve this? A doctor cannot do anything for me.
Barely able to walk - 102 degree fever - chills - body sweats - pins/needles - headache - dizziness.
Recieved shots 8/1 and noticed red, bumpy spots "like mosquito bites, but bigger" Reports he noticed the bumps on his left arm first which then spread to right arm and left leg.  Seen by MN who advised bendryl and cortisone.
Hives first appeared on 11/25/21.   Increased in frequency and severity through January.  Saw Primary Care Doc early Feb.   Then referred to Allergist, Rheumatologist, Dermatologist and Immunologist.
Vaccine given 7/30/07 at approximately 11am. Approximately 24 hours later, she complained of itching at the injection site.  Site on 7/31/07 at noon was red, hot to touch, with a 1"x2" hive.  The upper arm was slightly swollen and she complained of itching and slight pain.  Redness has now decreased, but hive remains.
Patient noticed swelling at injection site 09/19 in PM, redness appeared larger next day and moved to side of injection site, on 09/21 redness and swelling spread down to bicep and experienced fever and chills, on 9/22 reaction started to dissipate and on 09/23 almost gone-patient used ice and Tylenol and Claritin to treat.
Severe pain and swelling in left arm where injection site is, raised red lesions from injection site down to the elbow, hives to the face and trunk, severe headache and mouth sores.
Limb swelling; Chilling and nausea; Chilling and nausea; This spontaneous case was received on 16-Nov-2020 from other health professional (nurse) via Med Communications (reference number: SEQW20-05148) and concerned a 44-year-old, female patient.  The patient's concurrent condition included blood clots. The patient's concomitant medications included Aspirin (acetylsalicylic acid) for unreported indication.  On 13-Nov-2020, the patient was vaccinated with Flucelvax QIV (influenza vaccine, subunit influenza virus vaccine polyvalent, dose: 0.5 mL, route of administration: intramuscular and anatomical location: deltoid) as flu prophylaxis. The batch number reported was 279841 and expiry date was 30-Jun-2021.  On the same day, after receiving Flucelvax QIV, the patient experienced chilling and nausea.  On 15-Nov-2020, three days after receiving Flucelvax QIV, the patient developed swelling in her limb.  The outcome of the events was not reported.  The reporter did not provide a causality assessment.   The reporter assessed the case as non-serious.  This case is linked to case 202006418 (the same reporter).  Company comment: A 44-year-old, female patient was vaccinated with Flucelvax QIV. On the same day, after receiving Flucelvax QIV, the patient experienced chilling and nausea. Three days after receiving Flucelvax QIV, the patient developed swelling in her limb. Causality is assessed as possibly related for peripheral swelling, chills and nausea, due to plausible chronology.; Sender's Comments: A 44-year-old, female patient was vaccinated with Flucelvax QIV. On the same day, after receiving Flucelvax QIV, the patient experienced chilling and nausea. Three days after receiving Flucelvax QIV, the patient developed swelling in her limb. Causality is assessed as possibly related for peripheral swelling, chills and nausea, due to plausible chronology.
Swelling & tenderness to palpation L injection site & swelling at the R injection site x1 day.
I had COVID-19 after my vaccine. I had no fever but I had scratchy throat, runny nose and diarrhea. I had these symptoms for five days and I also had brain fog which lasted two weeks. I did a home test COVID-19 test which was positive in February 2023.  I had a telehealth visit with my doctor and he prescribed Paxlovid medication.  I have recovered from my symptoms.
Patient started experiencing Diarrhea, vomiting and fatigue  and developed what patient described as canker soar on his upper outer lip and tip of his tongue on 11/14/23 (the day he received the vaccine).  Per patient's wife: for the past 2 weeks, several family members experienced diarrhea and vomiting. One of their grand children was subsequently diagnosed with COVID-19.  the Diarrhea, vomiting and fatigue resolved within 2-3 days.  Patient still feels tired but he is always tired due to work schedules being long.  Patient refused to  see a doctor but used OTC Abreva to treat the cold soar on his upper lip and the symptoms improved. The only unresolved issue is the canker soar on his tongue.
no sx day of vax;awoke next AM @ 5:00 w/hives over trunk of body;saw MD 9AM unable to ID any other cause;started med @ 11AM on 12OCT had slowed down rxn, but still breaking out w/new hives today 17OCT96;
COVID 19 on present on admission:  Diagnosed  1/6/22 at Nursing home:  Pneumonia with acute respiratory failure and hypoxia.Tx w/prednisone,doxycycline,Oxygen
Developed a rash of small, red bumps covering my front torso at 8:00 am on 04/18/21 after the vaccination.  Rash was not itchy but stung a bit in the shower when I washed myself.  Rash subsided in 24 hours.  No treatment needed and no medicine taken.  Additionally, developed fever (100.4 deg), body aches, chills, headache, nausea, and fatigue overnight on day of vaccination, 04/16/21.  Those symptoms subsided by morning rash appeared, 04/18/21.  Soreness at vaccination site started within 1 hour of vaccination on 04/16/21 and redness at vaccination site started at 8:00 am on 04/18/21.  Soreness and redness at vaccination site subsided on 04/25/21.
Warm, red 4 X3 inch round mark on the back side of patient's arm. Pt felt feverish and ill.
The patient received the H1N1 flu vaccine on 11/09/09 at 2:30 PM. Later that night at 10:00 PM, the patient developed severe stomach pain with diarrhea, fever and headache. Patient has not contacted his doctor.
No specific treatment or reaction reported. This is in follow-up to report(s) previously submitted on 3/26/2008. Information has been received from a consumer concerning her son who on 23-JAN-2008 was accidentally vaccinated with a 0.65 ml dose of ZOSTAVAX (Merck). No AE was reported. It was unspecified if medical attention was sought. There were no lab studies performed.
10 minutes after COVID vaccine was administered, pt reported facial flushing to pharmacy staff. Per pt, her heart is pounding. RPh checked the blood pressure of the patient, blood pressure reading was 168/60, HR was 77. RPh spoke to another RPh in the store, RPh reported that BP was high for patient and per RPh if we administer EpiPen that can increase the patient's blood pressure even more. RPh gave the patient Benadryl 50 mg. RPh spoke to patient and patient's husband, he recommended to visit the nearest urgent care.
Approximately four hours after immunizations were given, the infant developed welts and edema of face, hands and feet. Child was sent to nearest ER. Dx: Urticaria  Benadry was given
Information has been received from an approximately 21 year old female consumer with no concomitant medications, no pertinent medical history and no drug reactions/allergies. The consumer reported in 2001, she received three doses of Hepatitis B vaccine (Recombinant) (lot number, expiration date and specific dates, route and site of administration not reported). The consumer reported in 2009, she was diagnosed with Asperger's syndrome. She has seen her health care provider and had unspecified blood work done. The consumer reported she has been institutionalized several times (no dates reported) for different time periods. The consumer reported the combination of being on "drugs" (no additional information provided regarding the type of drugs) and her Asperger's syndrome were the reasons she was hospitalized. At the time of the report, she was "feuding" with the people in the house where she lived. No further information provided. Additional information has been requested.
Report received via an literature study. The authors mined the FDA (Food and Drug Administration)/CDC (Center for Disease Control) Vaccine adverse event reporting system (VAERS) database and found 2 cases of cornea rejection after H1N1 vaccination. Outcome of patient is unknown.
This spontaneous report was received from a pharmacist referring to a patient of unknown age and gender. No concurrent or historical conditions were reported. On 23-DEC-2015, the patient was vaccinated with an improperly stored dose of ZOSTAVAX (Lot # L029482, expiration date 06-NOV-2016) dose, route and anatomical location were not provided. No concomitant medications were reported. No adverse effects were reported. No product quality complaint was involved. This is one of several cases received from the same reporter. Additional information has been requested.
pt recvd 3 doses of vax on 13OCT89 & 16NOV89 & 11MAY90; on 14DEC90 pt devel severe stiff neck which persisted for 10 days; on 23MAR91 neck stiffness returned & was noted to be moderate to severe & lasted for 4 days; aches, numbness, swellin